Does Self-Efficacy at the Start of Treatment Influence Treatment Outcome in Patients With EDs?

Condition(s) studied

Investigational drug(s) / intervention(s)

CBT-T: cognitive behavioral therapy-ten :

Study summary

The goal of this clinical trial is to contribute to the improvement of treatment for eating disorders, by identifying factors that might positively affect treatment outcome.

The main questions it aims to answer are:

1. Do higher levels of self-efficacy positively predict a more positive treatment outcome?
2. Does self-efficacy in itself improve during treatment?
3. Do autonomous motivation, self-esteem and self-efficacy correlate?

These factors will be measured in patients being treated for their eating disorders with Cognitive Behavior Therapy - Ten (CBT-T).

Researchers will administer questionnaires at start, session four and end of treatment.

Participants will:

1. Receive their treatment as usual.
2. fill in questionnaires at the start of treatment, session 4 and end of treatment.

Eligibility

Primary outcome measure(s)

• treatment outcome — CBT-T is a weekly, ten-session treatment. The ED-15 will be adminstered at the start of the first treatment session, at session 4 and at the end of treatment (session 10).: * week 1 * week 4 * week 10
  Eating Disorder-15 (ED-15) is a self-report questionnaire used to measure session-by-session change in eating pathology as part of the CBT-T protocol. All items are positively scored from 0-6, with higher scores reflecting higher levels of eating disorder pathology.

Trial sites (1)

Other trials for the same condition